Insulin injection at meal time or 30 min before: Effects on metabolic control in IDDM patients

Endocrinology and Metabolism, Supplement

Volumn 4, Issue 6, 1997, Pages 403-408

  Christensen, O ^a   Rosenfalck, A M ^b   Dejgaard, A ^c   Hilsted, J ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c Department of Internal Medicine and Endocrinology 157 ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; ISOPHANE INSULIN; NEUTRAL INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLIC REGULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TEST MEAL;

EID: 0031457101     PISSN: 1074939X     EISSN: 20935978     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. The Diabetes Control and Complications Trial Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N. Engl. J. Med. 1993; 329: 977-986.
2. Dimitriadis GD, Gerich JE. Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 1983; 6: 374-377.
3. Kraegen EW, Chisholm DJ, McNamara ME. Timing of insulin delivery with meals. Horm. Metab. Res. 1981; 13: 365-367.
4. Witt MF, White NH, Santiago JV. Roles of site and timing of the morning insulin injection in type 1 diabetes. J. Pediatr. 1983; 103: 528-533.
5. Lean MEJ, Ng LL, Tennison BR. Interval between insulin injection and eating in relation to blood glucose control in adult diabetics. Br. Med. J. 1985; 290: 105-108.
6. Patrick AW, Collier A, Matthews DM, Macintyre CCA, Clarke BF. The importance of the time interval between insulin injection and breakfast in determining postprandial glycaemic control - A comparison between human and porcine insulin. Diabetic Med. 1988; 5: 32-35.
7. Siddharth N, Pathar RB. Importance of timing of preprandial subcutaneous insulin injection in the management of diabetes mellitus. Diabetes Res. Clin. Prac. 1988; 5 (Suppl. 1)
8. Sackey AH, Jefferson IG. Interval between insulin injection and breakfast in diabetees. Arch. Disease Childhood 1994; 71: 248-250.
9. Pampanelli S, Torlone E, Lalli C, et al. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. Diabetes Care 1995; 18: 1452-1459.
10. Kinmonth AL, Baum JD. Timing of pre-breakfast insulin injection and postprandial metabolic control in diabetic children. Br. Med. J. 1980; 280: 604-606.
11. Jørgensen LN, Nielsen FS. Timing of pre-meal insulins in diabetic patients on a multiple daily injection regimen. A questionnaire study. Diabetologia 1990; 33: A116.
12. Grønlund B, Frandsen H, Lauritzen M, Levin Nielsen S, Madsbad S. Effects of insulin-induced hypoglycaemia on absorption of unmodified insulin after subcutaneous or intramuscular injection. Diabetic Med. 1991; 8: 13-17.
13. Garg SK, Carmain JA, Braddy KC, et al. Pre-meal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes. Diabetic Med. 1996; 13: 47-52.
14. Rowe R, Anderson JH, Gale E. A double-blind comparison of insulin LisPro and regular insulin in patients on a multiple injection regimen. Diabetes 1996; 45 (Suppl. 2): A253.
15. Pacaud D, Bourque J, Ducros F, et al. Premeal Lys/pro versus regular insulinnon postprandial glucose homeostasis. Diabetes 1996; 45 (Suppl. 2): A520.
16. Holleman F, Van Den Brand JJG, Hoven RARA, et al. Comparison of LysB28,ProB29 human insulin analog and human regular insulin in the correction of incidental hyperglycemia. Diabetes 1996; 45 (Suppl. 2): A1069.
17. Nielsen FS, Jørgensen LN, Ipsen M, Voldsgaard AI, Parving HH. Long-term comparison of human insulin analogue BlOAsp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen. Diabetologia 1995; 38: 592-598.
18. Pfutzner A, Gudat U, Trautmann ME. Longterm use of insulin lispro in intensive insulin therapy. Diabetes 1996; 45 (Suppl. 2): A1053.
19. Anderson J, Brunelle R, Pfuetzner A, Trautmann M, Vignati L. Reduced frequency of hypoglycemia without loss of glycemic control. Diabetes 1996; 45 (Suppl. 2): A211.